Clinical trial
A Pilot Study for the Treatment of Iris Neovascularization With Macugen
NCT00295828 · Hermann Eye Center, Other · Completed
Key facts
| NCT number | NCT00295828 |
|---|---|
| Title | A Pilot Study for the Treatment of Iris Neovascularization With Macugen |
| Official title | A Pilot Study for the Treatment of Iris Neovascularization With Macugen |
| Lead sponsor | Hermann Eye Center, Other |
| Collaborators | Eyetech Pharmaceuticals Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Iris Neovascularization, Diabetic Retinopathy |
| Intervention type | Other, Procedure |
| Interventions | Pegaptanib Sodium Injection/Panretinal Photocoagulation, Panretinal Photocoagulation (PRP) |
| Enrollment | 10 |
| Start date | Jan 1, 2006 |
| Primary completion | Sep 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Feb 24, 2006 |
| Last update posted | Sep 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: